Oxidative stress is implicated as a common pathologic mechanism contributing to the initiation and progression of hepatic damage in a variety of liver disorders. Present study attempts to evaluate the hepatoprotective activity of picroliv, curcumin and ellagic acid in comparison to silymarin using paracetamol (PCM) induced acute liver damage. Hepatotoxicity was induced by administering a single oral dose of PCM (500 mg/kg) and was assessed by quantifying the serum enzyme activities, phenobarbitone induced sleeping time and histopathological analysis of liver tissues. The antioxidant parameters, malondialdehyde (MDA), reduced glutathione (GSH) and catalase of the liver tissue were also assessed. The herbal drugs were administered for 7 days by oral route at 50 and 100 mg/kg. PCM induced hepatic damage was manifested by a significant increase in the activities of marker enzymes (alanine transaminase, aspartate transaminase and alkaline phosphatase) in serum and MDA level in liver. There was also a significant decrease in activity of GSH and catalase levels. The histopathological examination on toxic models revealed centrizonal necrosis and fatty changes. Pretreatment of mice with picroliv, curcumin and ellagic acid reversed these altered parameters towards normal values, which were compared with silymarin. The normalization of phenobarbitone induced sleeping time suggests the restoration of liver cytochrome P450 enzymes. This study supports the use of these active phytochemicals against toxic liver injury, which may act by preventing the lipid peroxidation and augmenting the antioxidant defense system or regeneration of hepatocytes. These active phytochemicals may be developed as drugs for the treatment of liver diseases.

No abstract

We have evaluated a new set of primers (TRC 4 ) in comparison with the IS6110 primers commonly used in PCR to detect tuberculous meningitis among children. The levels of concordance between the results of IS6110 PCR and TRC 4 PCR with cerebrospinal fluid specimens from patients with clinically confirmed tuberculous meningitis were 80 and 86%, respectively. Results with the two primer sets were concordant for 55 positive and 22 negative specimens (n ‫؍‬ 98). We conclude that the sensitivity of PCR can be increased by using both IS6110 and TRC 4 primers.Tuberculosis (TB) is the major cause of death worldwide and is due to a single pathogen (16). Childhood TB in general and TB meningitis in particular owe their existence to unsuspected, undiagnosed, or incompletely treated adults in the community. Among children, mortality due to TB occurs mainly due to the neural form of TB, namely, TB meningitis. About 3% of the pediatric admissions to hospitals in India are due to TB meningitis, with reported mortality ranging from 17 to 71% (2, 14). Prompt diagnosis is critical for initiating appropriate therapy and facilitating measures to prevent dissemination of this highly contagious disease. The prevalence of childhood TB meningitis remains largely underestimated because clinical manifestations are nonspecific in early stages of the disease and bacteriologic confirmation is available only for a small proportion of patients. Also, clinical diagnosis of childhood TB meningitis is difficult due to its varied clinical presentations. Further, routinely used tests employed for clinical diagnosis of TB are inadequate to detect extrapulmonary forms of TB like TB meningitis.PCR is currently the most sensitive and rapid method to detect extrapulmonary Mycobacterium tuberculosis (1,5,8,11,15). We used as a new target TRC 4 , which was cloned and characterized previously in our laboratory (10). TRC 4 is a conserved repetitive element with specificity for M. tuberculosis complex. The aim of this paper was to compare the efficiency of a PCR with a target chosen from this cloned fragment with that of a PCR with the widely used IS6110 sequence in detecting M. tuberculosis in cerebrospinal fluid (CSF) samples from children with meningitis.CSF specimens from children suffering from meningitis, aged to 12 years, were included in the study if at least four of the following seven indicators of disease were in evidence: first, the presence of clinical features, such as gradual loss of playful activity, irritability, clouding of consciousness, convulsions, neck stiffness, and cranial nerve or motor defects; second, a CSF lymphocyte count at admission greater than 10 ϫ 10 6 / liter; third, a CSF protein level at admission greater than 80 mg/dl; fourth, a CSF glucose/blood glucose ratio at admission of less than 0.5; fifth, contact with an intrafamilial adult positive for pulmonary TB; sixth, induration of 10 mm or more on tuberculin testing with 1 TU of purified protein derivative; and seventh, positive radiological features of primary complex in...

The use of herbal drugs for the treatment of liver diseases has a long tradition in many eastern countries. The easy accessibility without the need for laborious pharmaceutical synthesis has drawn increased attention towards herbal medicines. Few herbal preparations exist as standardized extracts with major known ingredients or even as pure compounds. Some of the herbals, which show promising activity, are ellagic acid for antifibrotic treatment, phyllanthin for treating chronic hepatitis B, glycyrrhizin to treat chronic viral hepatitis and picroliv for liver regeneration. These compounds, which have proven antioxidant, antiviral or anticarcinogenic properties, can serve as primary compounds for further development as hepatoprotective drugs. This review provides the chemistry, pharmacology and future aspects of picroliv, ellagic acid and curcumin with focus on hepatoprotective properties. These phytochemicals may prove to be very useful in the treatment of hepatotoxicity induced by viral agents, toxic drugs and plant poisons. The high safety profile may be an added advantage. However, poor bioavailability and temperature and light sensitivity can reduce the efficacy of drugs like curcumin. In future, the derivatives or new combinations of these drugs may prove to be useful.

No abstract